Is NCT07852728 recruiting in Boise, ID?

Yes, NCT07852728 is currently recruiting participants at its Boise, ID location. This traumatic brain injury clinical trial is actively enrolling qualified participants.

How do I join the traumatic brain injury clinical trial in Boise?

To join this clinical trial in Boise, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Boise clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Traumatic Brain Injury Clinical Trial in Boise, ID

About This Traumatic Brain Injury Study in Boise

The goal of this study is to examine changes in cognitive functioning and post-concussive symptoms following hyperbaric oxygen therapy (HBOT) in current and former first responders with a history of traumatic brain injury. The main questions it aims to answer are: 1. Do cognitive functioning and post-concussive symptoms change after 40 HBOT sessions? 2. Do symptoms of PTSD, depression, and anxiety, or quality of life, change after treatment? Approximately 54 participants will: * Complete medical and behavioral health screening. * Complete cognitive tests and questionnaires before and after treatment. * Receive 40 HBOT sessions at 2.0 atmospheres absolute (ATA), twice daily with at least four hours between sessions. All participants will receive HBOT. There is no comparison group, so the study cannot determine whether HBOT caused any observed changes.

Sponsor: Summit Hyperbarics and Wellness

Who Can Participate

Inclusion Criteria

Adults aged 18 to 75 years.

Current or former first responder.

Clinically diagnosed with a traumatic brain injury (TBI) and current or persistent post-concussive syndrome, as determined by a qualified health care professional.

Participants with comorbid PTSD, depression, or anxiety may be enrolled if all other eligibility criteria are met; these symptoms will be assessed as secondary/exploratory outcomes.

Ability to provide informed consent, including the ability to read, understand, and voluntarily sign the informed consent document.

Completion of baseline cognitive and psychological assessment measures as part of study enrollment procedures.

Presence of clinically significant symptoms resulting in functional impairment in occupational, social, or other key areas of functioning, as determined by clinical evaluation.

Sexually active female participants of childbearing potential and sexually active male participants with female partners of childbearing potential must agree to use an acceptable method of contraception for the duration of the study and for 30 days following the final HBOT session.

Stable regimen of psychoactive medications (if applicable), including antidepressants, anxiolytics, antipsychotics, stimulants, and mood stabilizers, for a clinically appropriate stabilization period prior to enrollment, as determined by the study physician.

Exclusion Criteria

Untreated pneumothorax

History of spontaneous pneumothorax

Severe sinus infection

Upper respiratory infection

Asymptomatic pulmonary lesions on chest x-ray

Uncontrollable high fever (greater than 39C)

History of chest or ear surgery

Congenital spherocytosis

Any anemia or blood disorder

Any convulsive disorder

History of optic neuritis or sudden blindness

Middle ear infection

Diabetes mellitus (insulin therapy)

The participant is pregnant or lactating

Nicotine use/substance use/addiction

Acute Hypoglycemia

Diagnosed Chronic Obstructive Pulmonary Disease (COPD) and Emphysema

Presenting with symptoms of cough, congestion, vomiting, diarrhea, or open wounds.

Active malignancy

Current manic, delusional, or psychotic episodes

Serious/current suicidal ideations

Severe or unstable physical disorders or major cognitive deficits

Inability to attend scheduled clinic visits or comply with study protocols.

Treated with HBOT for any reason prior to study enrollment.

Non-English speakers

History of retinal repair, including laser photocoagulation or retinal detachment surgery.

History of middle ear surgery, including tympanoplasty, mastoidectomy, or pressure equalization tube placement.

Age greater than 75 years.

Use of any of the following medications during the study period: Anti-metabolites (e.g., methotrexate, azathioprine); Chemotherapuetic agents (e.g., cyclophosphamide, cisplatin); Mafenide acetate e.g., Sulfamylon); Disulfiram (e.g, Antabuse); Peripheral vasodilators known to interact with oxygen exposure (e.g., nitroglycerin); and Antibacterial drugs with known HBOT interaction risks.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boise?

Yes, this clinical trial (NCT07852728) has an active research site in Boise, ID that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Traumatic Brain Injury Treatment Options in Boise, ID

If you're searching for traumatic brain injury treatment options in Boise, ID, this clinical trial (NCT07852728) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boise research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced traumatic brain injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all traumatic brain injury clinical trials near you to find additional studies recruiting in your area.

Traumatic Brain Injury Clinical Trial in Boise, ID

Expert Care in Boise

IRB Approved

No-Cost Care

Apply for This Boise Location

Why Participate?

Simple Process